Mastodon

Codesol® Pino (Drops) Instructions for Use

Marketing Authorization Holder

PharmVILAR NPO, LLC (Russia)

ATC Code

R01AX30 (Other nasal preparations for topical use in combination)

Dosage Form

Bottle OTC Icon Codesol® Pino Nasal drops: fl. 10 ml

Dosage Form, Packaging, and Composition

Nasal drops transparent, blue or blue-green in color with a characteristic odor.

100 g
Pine needle oil 3.752 g
Eucalyptus oil 0.5 g
Thymol 0.032 g
α-Tocopherol acetate 1.7 g
Peppermint oil 1 g
Guaiacol 0.02 g

Excipients: butylated hydroxyanisole – 0.012 g, macrogol and apricot kernel oil glycerides esters – 10 g, soybean oil – 2.984 g.

Excipients soybean oil – 80 g

10 ml – bottles – cardboard packs.

Clinical-Pharmacological Group

A drug with antimicrobial and anti-inflammatory action for topical use in ENT practice

Pharmacotherapeutic Group

Drugs for the treatment of nasal diseases; decongestants and other preparations for topical use; other drugs for the treatment of nasal diseases

Pharmacological Action

It has anti-inflammatory and antiseptic action.

Indications

  • Acute rhinitis.
  • Chronic atrophic rhinitis.
  • Acute and chronic inflammatory diseases of the nasal and nasopharyngeal mucous membranes accompanied by dryness of the mucous membranes.
  • Conditions after surgical intervention in the nasal cavity.

ICD codes

ICD-10 code Indication
J00 Acute nasopharyngitis (common cold)
J31.0 Chronic rhinitis (including ozaena, atrophic and hypertrophic rhinitis)
J31.1 Chronic nasopharyngitis
Z98.8 Other specified postprocedural states
ICD-11 code Indication
CA00 Acute nasopharyngitis
CA09.0 Chronic rhinitis
CA09.1 Chronic nasopharyngitis
QB6Z Surgical or postprocedural conditions, unspecified

Dosage Regimen

The method of application and dosage regimen for a specific drug depend on its form of release and other factors. The optimal dosage regimen is determined by the doctor. It is necessary to strictly adhere to the compliance of the dosage form of a specific drug with the indications for use and dosage regimen.

Administer topically into the nasal cavity.

Instill 1-2 drops into each nasal passage 3-4 times/day.

Use the drug for inhalations as an alternative method of administration.

Limit the duration of treatment to 5-7 days.

Adverse Reactions

Local reactions frequency unknown: itching, burning, dryness, hyperemia or swelling of the nasal mucosa, nasal discomfort.

From the immune system frequency unknown: hypersensitivity reactions to the drug.

Contraindications

  • Hypersensitivity to any component of the drug.
  • Allergic rhinitis.
  • Children under 2 years of age.

Use in Pregnancy and Lactation

The drug can be used during pregnancy and breastfeeding.

Pediatric Use

Contraindicated for use in children under 2 years of age.

Special Precautions

Avoid contact of the drug with the mucous membrane of the eyes.

Frequent and/or prolonged use of the drug may lead to dryness of the nasal mucosa.

Storage Conditions

Store at 15°C (59°F) to 25°C (77°F). Keep in original packaging, protected from light. Keep out of reach of children.

Dispensing Status

Over-the-Counter

Important Safety Information

This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.

Medical Disclaimer

TABLE OF CONTENTS